In this exclusive Drug Digest video, Adi Kaushal from Lonza summarizes the current state of the oral solid dosage market, identifies the main challenges to drug developers, explains how CDMOs are ...

Mirai Bio and Thermo Fisher partner to integrate AI-driven design with CGMP manufacturing, aiming to streamline development ...

Grifols received FDA clearance to begin a Phase II trial of GRF312, an immunoglobulin eye drop for dry eye disease, aiming to ...

In this episode of the Ask the Expert video series, Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, and Siegfried Schmitt, PhD, vice president, Technical at Parexel, ...

Inobrodib is being developed as a first-in-class oral cancer drug that the company says will be able to treat not only ...

ACG partnered with Art of You to launch the world-first Personalised Capsule Machine, enabling on-demand, customized ...

The LP.8.1 variant of the SARS-CoV-2 virus differs from the JN.1 family that previous vaccines had been designed to target, ...

Researchers say they have discovered the first drug mechanism that binds to the pyrin domain to block NLRP3 and prevent a series of reactions resulting in inflammation.

The API is, one might say, the most important element in a pharmaceutical product. Poor-quality APIs that do not meet potency ...

The proposed $700 million, 700,000-square-foot space will support the companies’ future joint portfolio of next-generation ...

According to the White House, the order builds on actions taken in the president’s first term to reduce price disparities ...

Scientific, economic, and practical factors should be considered when choosing between the frozen state and lyophilization.